Experience With the Use of Baricitinib and Tocilizumab Monotherapy or Combined, in Patients With Interstitial Pneumonia Secondary to Coronavirus COVID19: A Real-World Study

Frontiers Efficacy and safety of tocilizumab and baricitinib

Full article: Therapeutic and anti-inflammatory effects of

The signal pathways and treatment of cytokine storm in COVID-19

Role of baricitinib in COVID-19 patients: A systematic review and

Frontiers Targeting the Immune System for Pulmonary Inflammation

IJMS, Free Full-Text

Frontiers Efficacy and safety of tocilizumab and baricitinib

Baricitinib reduces 30‐day mortality in older adults with moderate

Tocilizumab versus baricitinib in hospitalized patients with

Frontiers Efficacy and safety of tocilizumab and baricitinib

Frontiers The Efficacy and Safety of Janus Kinase Inhibitors for